altretamine has been researched along with fluorouracil in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 60 (82.19) | 18.7374 |
1990's | 6 (8.22) | 18.2507 |
2000's | 3 (4.11) | 29.6817 |
2010's | 4 (5.48) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Gaeta, JF; Mirand, EA; Murphy, GP; Varkarakis, MJ | 1 |
Carter, SK; Wasserman, TH | 1 |
Asserkritova, IV; Garin, AM; Lichinitser, MR; Perevodchikova, NI; Vaarik, GKh | 1 |
Anderson, T; Bender, RA; Canellos, GP; Chabner, BA; DeVita, VT; Fisher, RI; Hubbard, SP; Simon, RM; Young, RC | 1 |
Neijt, JP; Pinedo, HM; Roozendaal, KJ; Struyvenberg, A; van Lindert, AC; Vendrik, CP | 1 |
Costa, J; Garvin, AJ; Ozols, RF; Simon, RM; Young, RC | 1 |
Alberts, DS; Hilgers, RD; Martimbeau, PW; Moon, TE; Rivkin, S | 1 |
Fisher, RI; Young, RC | 2 |
Rutledge, F; Smith, JP; Stanhope, CR | 1 |
Fraumeni, JF; Hoover, R; Reimer, RR; Young, RC | 1 |
Bruntsch, U; Gallmeier, WM | 2 |
Blessing, J; Lewis, GC | 1 |
Kardinal, CG; Luce, JK | 1 |
Barber, HR; Buterman, I; Kakarla, R; Kwon, T | 1 |
Cruz, AB; Davis, HL; Fletcher, WS; Golomb, FM; Grage, T; Hill, GJ; Johnson, RO; Metter, G; Wilson, WL | 1 |
Rutledge, FN; Smith, JP | 2 |
Canellos, GP; Chabner, BA; DeVita, VT; Hubbard, SP; Young, RC | 1 |
Young, RC | 2 |
Aartsen, E; Heintz, AP; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Lent, M; van Lindert, AC; van Oosterom, AT; Vermorken, JB; Willemse, PH | 1 |
Hansen, LA; Hughes, TE | 1 |
Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van der Hoop, RG; van Houwelingen, C | 1 |
Hansen, HH; Hansen, M; Lund, B; Lundvall, F; Nielsen, NC; Sørensen, BL; Thomsen, HK | 1 |
Barbé-Gaston, C; Bécouarn, Y; Brunet, R | 1 |
Gröhn, P; Heinonen, E; Kivinen, S; Sipilä, P; Vesala, J | 1 |
Bruckner, HW; Butwell, N; Gorbaty, MI; Kalman, J; McKenna, A; Spigelman, M; Storch, J | 1 |
Cederbaum, AI; Griffin, TW; Halpin, TF; Hunter, RA; Liepman, MK; Meyer, RN; Schwartz, JH; Strauss, GM; Tak, WK; Ward, AD | 1 |
Neijt, JP; ten Bokkel Huinink, WW; Van der Burg, ME; van Oosterom, AT | 1 |
Burnett, LS; Greco, FA; Grosh, WW; Jones, HW | 1 |
Ashikaga, T; Belinson, JL; McClure, M; Pretorius, RG | 1 |
Blouin, R; de Gramont, A; Dray, C; Drolet, Y; Krulik, M; Lavoie, A; Louvet, C; Painchaud, M; Pigné, A; Tessier, C | 1 |
Alberts, DS; Green, JB; Hilgers, RD; Laufman, LR; Lin, F; O'Toole, R; Rivkin, SE; Young, DC | 1 |
Howser, D; Jenkins, J; Louie, KG; Myers, CE; Ostchega, Y; Ozols, RF; Young, RC | 1 |
Wu, BZ | 1 |
Heintz, AP; Nooy, M; Schaberg, A; Trimbos, JB; Van der Velde, EA; Van Oosterom, AT | 1 |
Carchman, RA; Carter, WH | 1 |
Delgado, G; Edwards, BK; Marantz, AB; Posada, JG; Schein, PS; Smith, FP; Yeung, KY | 1 |
Delgado, G; McLaughlin, EK; Smith, FP; Tuholski, N | 1 |
Howell, SB; Lucas, WE; Markman, M | 1 |
Ballard, WP; Coleman, M; Pasmantier, MW; Silver, RT | 1 |
Budzik, GP; Donahoe, PK; Fuller, AF; Krane, IM | 1 |
Botts, B; Carlson, JA; Day, TG; Masterson, BJ | 1 |
Ozols, RF | 1 |
Hamerlynck, JV; Kooyman, CD; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Houwelingen, JC; van Lent, M; van Lindert, AC; van Oosterom, AT; Vriesendorp, R | 1 |
Carmo-Pereira, J; Costa, FO; Henriques, E; Ricardo, JA | 1 |
Brissaud, P; de Gramont, A; Debray, J; Hubert, D; Krulik, M; Pigne, A; Sirinelli, A; Zylberait, D | 1 |
Burnett, LS; Greco, FA; Hainsworth, JD; Johnson, DH; Jones, HW; Malcolm, A | 1 |
Brown, JC; Bruckner, HW; Chamberlin, K; Goldberg, J; Storch, JA | 2 |
Erba, E; Garattini, S; Ghelardoni, C; Landoni, F; Mangioni, C; Morasca, L; Sessa, C; Vaghi, M | 1 |
Bruning, PF; Hamerlynck, JV; Schellekens, PT; ten Berge, RJ | 1 |
Maggino, T; Onnis, A | 1 |
Calciati, A; Clerico, M; Donadio, M; Giaccone, G | 1 |
Dembo, AJ | 1 |
Ozols, RF; Young, RC | 1 |
Davis, TE; Gilchrist, KW; Neville, AJ | 1 |
Braun, DP; Harris, JE | 1 |
Grigorova, TM; Marenich, AF; Vartanian, LG | 1 |
Burnett, L; Greco, FA; Hande, KR; Julian, CG; Oldham, RK; Richardson, RL | 1 |
De Lena, M; De Palo, G; Demicheli, R; Valagussa, P; Villa, E | 1 |
Chang, YC; Crowley, J; Falkson, G; Tormey, DC | 1 |
Bolis, G; Colombo, N; D'Incalci, M; Mangioni, C; Sessa, C; Valente, I | 1 |
Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Livartowski, A; Palangie, T; Pouillart, P | 1 |
8 review(s) available for altretamine and fluorouracil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The integration of chemotherapy into combined modality treatment of solid tumors. VIII. Cervical cancer.
Topics: Alkylating Agents; Altretamine; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Radiotherapy, High-Energy; Radium; Uterine Cervical Neoplasms; Vaginal Smears | 1977 |
Chemotherapy of ovarian cancer.
Topics: Alkylating Agents; Altretamine; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms | 1978 |
Chemotherapy of ovarian cancer: past and present.
Topics: Acrylates; Alkylating Agents; Altretamine; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Maryland; Methotrexate; Ovarian Neoplasms; Porfiromycin; Procarbazine; Progestins | 1975 |
Hexamethylmelamine (altretamine): early National Cancer Institute trials.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; National Institutes of Health (U.S.); Neoplasm Staging; Ovarian Neoplasms; United States | 1991 |
Altretamine.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Interactions; Female; Fluorouracil; Humans; Lung Neoplasms; Methotrexate; Ovarian Neoplasms | 1991 |
Radiotherapeutic management of ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leukemia; Melphalan; Ovarian Neoplasms | 1984 |
Chemotherapy of ovarian cancer.
Topics: Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Estrogen Antagonists; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Ovarian Neoplasms; Progestins; Tamoxifen | 1984 |
22 trial(s) available for altretamine and fluorouracil
Article | Year |
---|---|
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Agents; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Ovarian Neoplasms; Prospective Studies | 1978 |
Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.
Topics: Altretamine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Triazines | 1979 |
Histologic grade in advanced ovarian cancer.
Topics: Altretamine; Cell Differentiation; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Ovarian Neoplasms; Prognosis | 1979 |
Advances in the staging and treatment of ovarian cancer.
Topics: Alkylating Agents; Altretamine; Antimetabolites, Antineoplastic; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Laparoscopy; Lymphatic Metastasis; Lymphography; Melphalan; Neoplasm Metastasis; Ovarian Neoplasms | 1977 |
Second trial drugs in ovarian cancer.
Topics: Altretamine; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Thiotepa | 1977 |
Ovarian cancer: use of multiple modality programs involving surgery, radiation therapy and chemotherapy.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Melphalan; Ovarian Neoplasms; Propionibacterium acnes; Radiotherapy Dosage | 1977 |
Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian carcinoma.
Topics: Altretamine; Bone Marrow; Clinical Trials as Topic; Digestive System; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Ovarian Neoplasms; Pilot Projects; Triazines | 1977 |
Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Maryland; Melphalan; Methotrexate; National Institutes of Health (U.S.); Ovarian Neoplasms; Prospective Studies; United States | 1975 |
Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.
Topics: Adult; Altretamine; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1975 |
Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Staging; Netherlands; Ovarian Neoplasms; Prognosis; Time Factors | 1991 |
Hexamethylmelamine (altretamine): early National Cancer Institute trials.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; National Institutes of Health (U.S.); Neoplasm Staging; Ovarian Neoplasms; United States | 1991 |
Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Nervous System Diseases; Ovarian Neoplasms; Prospective Studies | 1990 |
A randomized study of sequential versus alternating combination chemotherapy in advanced ovarian carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Survival Rate | 1990 |
Complete remission at laparotomy: still a gold standard in ovarian cancer?
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Laparotomy; Methotrexate; Ovarian Neoplasms; Random Allocation | 1986 |
Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group Study.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Resistance; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms | 1986 |
Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Random Allocation; Reoperation | 1986 |
The case for combination chemotherapy in the treatment of advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms | 1985 |
Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms; Paresthesia; Prognosis; Random Allocation; Reoperation; Time Factors | 1984 |
Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF).
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Prognosis; Prospective Studies | 1981 |
Combination chemotherapy and immune capacity in advanced ovarian carcinoma.
Topics: Adult; Aged; Altretamine; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytotoxicity, Immunologic; Doxorubicin; Female; Fluorouracil; Humans; Immunity, Cellular; Leukocyte Count; Lymphocyte Activation; Methotrexate; Middle Aged; Ovarian Neoplasms | 1984 |
Radiotherapeutic management of ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leukemia; Melphalan; Ovarian Neoplasms | 1984 |
[Treatment of cancers of the ovary. Phase II trial of increase of the dose of cisplatin].
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Postoperative Care; Remission Induction | 1993 |
45 other study(ies) available for altretamine and fluorouracil
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Morphological responses of benign human prostatic hypertrophic tissue to chemotherapeutic agents in an in vitro culture system.
Topics: Aged; Altretamine; Dacarbazine; Fluorouracil; Humans; Lomustine; Male; Microscopy; Middle Aged; Organ Culture Techniques; Procarbazine; Prostate; Prostatic Hyperplasia; Streptozocin; Vincristine | 1975 |
[Effectiveness of ftorafur and hexamethylmelamine in advanced breast cancer].
Topics: Adult; Altretamine; Breast Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Middle Aged; Neoplasm Metastasis; Tegafur; Triazines | 1978 |
Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.
Topics: Alkylating Agents; Altretamine; Antineoplastic Agents; Bone Marrow; Cisplatin; Doxorubicin; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Humans; Ovarian Neoplasms | 1979 |
Acute leukemia after alkylating-agent therapy of ovarian cancer.
Topics: Acute Disease; Alkylating Agents; Altretamine; Chlorambucil; Cyclophosphamide; Female; Fluorouracil; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Melphalan; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Risk; Thiotepa; Time Factors; Uracil Mustard | 1977 |
[Chemotherapy of the ovarian carcinoma (author's transl)].
Topics: Altretamine; Antineoplastic Agents; Chlorambucil; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxyprogesterones; Mechlorethamine; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Nitrosourea Compounds; Ovarian Neoplasms; Thiotepa; Vinblastine; Vincristine | 1977 |
Current concepts in the management of ovarian cancer.
Topics: Adult; Aged; Altretamine; Castration; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; United States | 1978 |
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mitolactol; Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Rectal Neoplasms; Vincristine | 1976 |
Chemotherapy in advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1975 |
Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Unknown Primary | 1989 |
Phase II evaluation of peroral carmofur, cyclophosphamide, and hexamethylmelamine as a second-line therapy in advanced epithelial ovarian carcinoma.
Topics: Administration, Oral; Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Prospective Studies | 1989 |
Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Fluorouracil; Humans; Infusions, Intravenous; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms | 1989 |
Treatment of advanced ovarian cancer with sequential combination chemotherapy.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 1987 |
Malignant mixed mesodermal tumors of the uterus and ovary treated with cisplatin-based combination chemotherapy.
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Time Factors; Uterine Neoplasms | 1986 |
Hexamethylmelamine, methotrexate, 5-fluorouracil as second line chemotherapy after platinum for epithelial ovarian malignancies.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hormones; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Peptichemio | 1986 |
[Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Staging; Ovarian Neoplasms | 1986 |
[Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Female; Fluorouracil; Humans; Ovarian Neoplasms; Prospective Studies; Thiotepa | 1987 |
The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Hysterectomy; Methotrexate; Ovarian Neoplasms; Ovariectomy; Postoperative Care; Prognosis; Regression Analysis | 1988 |
Mathematical and biostatistical methods for designing and analyzing complex chemical interactions.
Topics: Altretamine; Animals; Cisplatin; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Mice; Mice, Inbred Strains; Models, Chemical; Razoxane; Sister Chromatid Exchange; Statistics as Topic | 1988 |
The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Hysterectomy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Reoperation | 1985 |
Single agent vs. combination chemotherapy for ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Random Allocation; Time Factors | 1985 |
Intraperitoneal chemotherapy for advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms; Peritoneal Cavity; Thiosulfates | 1985 |
Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Topics: Adenocarcinoma; Age Factors; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms | 1985 |
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Topics: Adenocarcinoma; Altretamine; Anti-Mullerian Hormone; Ascitic Fluid; Carcinoma; Chromatography, Affinity; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Fallopian Tube Neoplasms; Female; Fluorouracil; Genital Neoplasms, Female; Glycoproteins; Growth Inhibitors; Humans; In Vitro Techniques; Lung Neoplasms; Melanoma; Ovarian Neoplasms; Testicular Hormones; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 1985 |
Hexamethylmelamine, methotrexate and 5-fluorouracil (HMF) for progressive ovarian carcinoma during therapy with cis-platinum, cyclophosphamide +/- doxorubicin.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Reoperation | 1985 |
[Treatment of advanced ovarian cancer].
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis | 1984 |
Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiation Injuries | 1983 |
Phase II trial of combination chemotherapy of colonic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
Topics: Altretamine; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Triazines | 1983 |
Phase II trial of combination chemotherapy for pancreatic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
Topics: Altretamine; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Mitomycin; Mitomycins; Pancreatic Neoplasms; Triazines | 1983 |
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms | 1983 |
[Chemotherapy of epithelial ovarian carcinoma].
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chlorambucil; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms | 1983 |
Repetitive debulking surgery as adjuvant to chemotherapy in advanced epithelial ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Prospective Studies; Reoperation | 1984 |
[Chemotherapy in advanced forms of carcinoma of the ovary].
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Ovarian Neoplasms | 1984 |
The chemotherapy of granulosa cell tumors of the ovary: experience of the Wisconsin Clinical Cancer Center.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulosa Cell Tumor; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prednisone; Retrospective Studies; Vincristine | 1984 |
Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Cell Adhesion; Drug Therapy, Combination; Fluorouracil; Humans; Immunity, Cellular; Indomethacin; Leucovorin; Lymphocyte Activation; Methotrexate; Middle Aged; Mitomycins; Monocytes; Neoplasms; Phytohemagglutinins; T-Lymphocytes, Regulatory; Time Factors | 1981 |
[Surgical method and combination chemotherapy in treating stage-III and IV ovarian cancer].
Topics: Altretamine; Antineoplastic Agents; Carcinoma; Cyclophosphamide; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms; Ovary; Postoperative Care; Tegafur; Time Factors | 1980 |
Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms | 1981 |
Prospective study with HEXA-CAF combination in ovarian carcinoma.
Topics: Altretamine; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Ovary | 1981 |
Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukopenia; Middle Aged; Nausea; Prednisone | 1981 |
Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Triazines | 1982 |